A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma

Journal of Negative Results in BioMedicine

Volumn 12, Issue 1, 2013, Pages

  Murphy, Kevin ^a   Gawchik, Sandra ^b   Bernstein, David ^c   Andersen, Jens ^d   Pedersen, Martin Rud ^d  

^a BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^b Asthma and Allergy Research Associates   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d ALK ABELLÓ   (Denmark)

Author keywords

Allergic conjunctivitis; Allergic rhinitis; Allergic rhinoconjunctivitis; Allergy immunotherapy tablet; Randomized controlled trial; Specific immunotherapy; Sublingual immunotherapy

Indexed keywords

ANTIALLERGIC AGENT; GRASS ALLERGY IMMUNOTHERAPY TABLET; PLACEBO; UNCLASSIFIED DRUG; GRASS POLLEN EXTRACT, ALUM-ADSORBED; PLANT ANTIGEN; PLANT EXTRACT; TABLET;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CONJUNCTIVITIS; CONTROLLED STUDY; DAILY MEDICATION SCORE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EAR PRURITUS; FEMALE; GRASS POLLEN; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; LYOPHILISATE; MAJOR CLINICAL STUDY; MALE; MOUTH EDEMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; ORAL PARESTHESIA; ORAL PRURITUS; PHASE 3 CLINICAL TRIAL; PHLEUM PRATENSE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; RHINOPHARYNGITIS; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; ADOLESCENT; ANAPHYLAXIS; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; CONJUNCTIVITIS, ALLERGIC; DOUBLE BLIND PROCEDURE; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RHINITIS, ALLERGIC, SEASONAL; TABLET; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANTIGENS, PLANT; ASTHMA; CONJUNCTIVITIS, ALLERGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PLANT EXTRACTS; RHINITIS, ALLERGIC, SEASONAL; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878353196     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-12-10     Document Type: Article

References (14)

1. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R, J Allergy Clin Immunol 2012 129 717 725 e5 10.1016/j.jaci.2011.12.973 22285278
2. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, Passalacqua G, Potter P, Valovirta E, Allergy 2007 62 317 324 10.1111/j.1398-9995.2006.01312.x 17298350
3. Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI, Ann Allergy Asthma Immunol 2011 107 426 431 e1 10.1016/j.anai.2011.05.020 22018614
4. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. Bernstein DI, Wanner M, Borish L, Liss GM, Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology, J Allergy Clin Immunol 2004 113 1129 1136 10.1016/j.jaci.2004.02.006 15208595
5. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P, Allergy 2012 67 302 311 10.1111/j.1398-9995.2011.02761.x 22150126
6. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Bousquet J, Schünemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB, Demoly P, Durham S, Carlsen KH, Malling HJ, Passalacqua G, Simons FE, Anto J, Baena-Cagnani CE, Bergmann KC, Bieber T, Briggs AH, Brozek J, Calderon MA, Dahl R, Devillier P, Gerth van Wijk R, Howarth P, Larenas D, Papadopoulos NG, Schmid-Grendelmeier P, Zuberbier T, Allergy 2011 66 765 774 10.1111/j.1398-9995.2011.02590.x 21496059
7. Recommendations for appropriate sublingual immunotherapy clinical trials. Casale TB, Canonica GW, Bousquet J, Cox L, Lockey R, Nelson HS, Passalacqua G, J Allergy Clin Immunol 2009 124 665 670 10.1016/j.jaci.2009.07.054 19766297
8. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR, J Allergy Clin Immunol 2006 118 434 440 10.1016/j.jaci.2006.05.003 16890769
9. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Knecht R, Stephan V, Tholstrup B, Weisshaar C, Kaiser F, J Allergy Clin Immunol 2009 123 167 173 e7 10.1016/j.jaci.2008.10.044 19130937
10. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S, J Allergy Clin Immunol 2006 117 802 809 10.1016/j.jaci.2005.12.1358 16630937
11. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Dahl R, Stender A, Rak S, Allergy 2006 61 185 190 10.1111/j.1398-9995.2005.00949.x 16409194
12. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI, J Allergy Clin Immunol 2011 127 72 80 80.e1-2 10.1016/j.jaci.2010.11.035 21211643
13. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP, J Allergy Clin Immunol 2011 127 64 71 71.e1-4 10.1016/j.jaci.2010.11.034 21211642
14. Efficacy and safety of the SQ-standardised grass allergy immunotherapy tablet in mono- and polysensitised subjects. Nelson HS, Blaiss M, Nolte H, Würtz SØ Andersen JS, Durham SR, Allergy 2013 68 252 255 10.1111/all.12074 23205670